Should the usual threshold for prostate biopsy be lowered from 4.0 to 2.5 ng/mL for healthy men with a life expectancy of well over 10 years?

Share this article:

The National Cancer Institute estimated that 240,890 men would be diagnosed with prostate cancer in the United States in 2011. Many clinicians believe the disease is being overdiagnosed and overtreated, yet some researchers have advocated decreasing the PSA threshold for prostate biopsy from the conventional 4.0 ng/mL to 2.5 ng/mL in an attempt to pick up prostate cancers that are now being missed. Critics say this could exacerbate the problem of overdiagnosis and lead to even more men being treated unnecessarily.

Renal & Urology News would like to know what you think, so please answer the following poll question.

Leave a comment below on why you chose your answer. If your answer doesn't match one of our choices, please let us know why.

Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

Are you more likely to perform partial rather than radical nephrectomy for tumors if robotic-assisted surgery is available?

Are you more likely to perform partial rather ...

Availability of robotic-assisted surgery at a hospital was independently associated with greater use of partial nephrectomy.

What proportion of your hospitalized patients is cared for by hospitalists?

What proportion of your hospitalized patients is cared ...

More and more inpatient care is being provided by hospitalists.

Has the proportion of your patients undergoing prostate brachytherapy been declining?

Has the proportion of your patients undergoing prostate ...

Prostate cancer patients undergoing radical prostatectomy increased by double digits while those undergoing brachytherapy decreased.